University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
NCT Number: NCT00062608
The aims are to evaluate: (1) the effectiveness of written self-disclosure (WSD) on health status of youth ages 12-18 with functional recurrent abdominal pain (RAP); (2) whether effectiveness of WSD is similar for younger (12-14) and older (15-18) youth with functional RAP; and (3) the feasibility and acceptability of WSD when extended to the pediatric health care setting.We will implement a randomized, controlled trial (RCT) designed to compare health status in 140 youths (ages 12-18) with functional RAP assigned either to standard medical care (SMC) or WSD provided in the health care setting in addition to SMC. Health status will be measured at Baseline and 3- and 6-months thereafter. Primary measures of health status are symptom severity and episode frequency, consistent with the definition of RAP. Secondary measures of health are functional health, psychological distress, health-related quality of life, and health care utilization. Total use and diagnostic tests will index health care utilization, collected for the 6-mos prior to and following Baseline. Mixed model ANOVA or MANOVA will be used to test directional hypotheses corresponding to the specific aims.
Looking for future studies?
Notify Me12 year–18 year
All sexes
Interventional
Phase 2 / Phase 3
Birmingham, Alabama, 35294, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Nih
RCT of Written Self-disclosure for Youth Abdominal Pain
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05998369
Abdominal Pain, Autonomic Nervous System Diseases
Palo Alto, California, United States
View Trial DetailsNCT06268717
Abdominal Pain, Alpha-Gal Syndrome
Chapel Hill, North Carolina, United States
View Trial DetailsNCT07643142
Abdominal Pain, Acute Appendicitis
Istanbul, ATASEHIR, Turkey (Türkiye)
View Trial DetailsNCT02711800
Abdominal Pain, Anxiety
Durham, North Carolina, United States
View Trial Details